MUSCAT GROUP Inc. Full-Year Earnings Flash

Revenue reached JPY 4.1B with robust +38% YoY growth, driven by accelerating M&A-led expansion of proprietary brand portfolio; however, restructuring charges pushed operating profit into the red — focus shifts to the path back to profitability and a return to the growth trajectory next fiscal year

PublishedMay 14, 2026 at 20:00 GMT+9

Key Positives From The Results

The consolidation of Kanarabo (Fujiko/b idol), HaD (bialne), and a full-year contribution from Matsumura Shoten drove revenue to JPY 4,129M, up +38.3% YoY. Proprietary brand revenue doubled to JPY 2,266M (+125.5% YoY), marking meaningful progress in the qualitative transformation of the business portfolio. Adjusted net income of JPY 310M (+95.0% YoY) was secured by booking gains on the divestiture of unprofitable operations, striking a balance between restructuring and profit generation — a noteworthy achievement.

  • Proprietary Brand Revenue
    of JPY 2,266M (+125.5% YoY): H2 Fujiko revenue of JPY 538M was the key driver, broadening the earnings base across the brand portfolio
  • PMI-Driven E-Commerce Growth
    : Fujiko EC revenue +48.6%, Matsumura Shoten EC revenue +538.6%, validating the repeatability of the "acquire and grow" brand development model
  • Decisive Exit From Unprofitable Operations
    : Booked JPY 304M in goodwill impairment on the RiLi casting business and JPY 645M gain on the sale of Rice Curry LS, eliminating future risk overhangs
  • Organic Growth Signals
    : bialne subscription retention rate at 94.8%; MiiS new product "mm flora*Bubble" surpassed 20,000 cumulative units within two months of launch
  • Governance Upgrade
    : Transition to a holding company structure strengthened group governance and established a framework enabling autonomous management at each subsidiary

Key Concerns From The Results

Operating loss of JPY -399M (vs. operating income of JPY 88M in the prior year) represented a sharp deterioration in profitability. Gross margin declined to 53.6% (-0.7pt YoY), pressured by rising raw material/logistics costs and FX volatility. SG&A ballooned to JPY 2,612M (+70.2% YoY), primarily due to M&A-related expenses and higher corporate overhead, though the line between one-off and structural cost increases remains unclear and warrants caution.

  • Operating Cash Flow
    of JPY -673M (vs. JPY -407M prior year) marks a second consecutive year of negative OCF — restoring cash generation is an urgent priority
  • Goodwill Balance
    surged to JPY 2,311M (+JPY 1,549M YoY), now representing 40.9% of total assets, amplifying risk associated with the M&A-dependent growth model
  • Equity Ratio
    deteriorated to 19.2% (from 32.7%), with interest-bearing debt rising to JPY 3,541M (+JPY 1,553M YoY) — financial leverage has expanded rapidly
  • Kanarabo Retail Channels
    : Sales at variety stores and other key channels underperformed initial plans amid intensifying competition and shifting consumer behavior
  • Deferred Tax Asset Reversal
    of JPY 205M stemmed from the restructuring of intra-group profit flows following the holding company transition — stability of future tax effects requires close monitoring

Focus Areas / Items To Monitor Going Forward

  • Achievability of the FY2027 revenue plan of JPY 6,602M (+59.9%), driven by the full-year consolidation of Kanarabo. Key variables include normalization of return rates in Fujiko/b idol's retail channels and the revenue contribution from the new "Pore-Smoothing Cream" product
  • The FY2027 operating income target of JPY 50M presumes a return to profitability at the business level. Monitor progress on gross margin improvement and advertising spend optimization to absorb ~JPY 500M in holding company management costs and ~JPY 200M in goodwill amortization
  • Under VISION2029, the mid-term plan targets revenue of JPY 15B and operating income of JPY 1.5B by FY2029. Assess whether executing 2–5 M&A deals annually while maintaining PMI quality is realistic, with particular attention to goodwill impairment risk management
Discussion Points For Management
  • Specific shelf-space strategies and price pass-through plans to counter intensifying competition in Kanarabo's core channel (variety stores)
  • Quantitative impact outlook for advertising spend optimization and AI-driven outsourcing cost reduction toward achieving the FY2027 operating income target of JPY 50M
  • Impairment testing methodology for the JPY 2,311M goodwill balance, and individual assessments of goodwill recoverability by subsidiary
  • Concrete timeline for Middle East market entry and expected timing of revenue contribution from the KLab business alliance
  • Rollout schedule for extending Fujiko's 13.0% Greater China revenue share to other brands via shared distribution channels
  • Trends in LTV and customer acquisition cost (CAC) for bialne's subscription model
  • Balancing autonomous management of group companies under the holding company structure with centralized PMI and governance oversight
  • M&A financing policy (equity vs. debt mix) given the current JPY 3,541M debt load and 19.2% equity ratio
  • Rebranding plan and launch timeline following the acquisition of WHOMEE sales rights
  • Monetization timeline for the clinic business (Tokakai, MOM, Harukikai) and quantification of cross-sell synergies with the MiiS brand

Key Financial Highlights

ItemValueYoY
RevenueJPY 4,129M+38.3%
Gross ProfitJPY 2,213M+37.4%
Gross Profit Margin53.6%-0.7pt
Operating IncomeJPY -399M-
Recurring ProfitJPY -451M-
Net Income Attributable to Owners of Parent CompanyJPY -368M-
Adjusted EBITDAJPY -118M-
Adjusted Net IncomeJPY 310M+95.0%
EPSJPY -121.46-
Book Value Per ShareJPY 317.57-19.0%
Comprehensive IncomeJPY -451M-
Operating CFJPY -673M-
Investing CFJPY -629M-
Financing CFJPY +1,305M+0.1%
Cash and Cash Equivalents (End of Period)JPY 689M+26.8%

Revenue achieved 100.7% of the revised guidance of JPY 4,100M. Operating loss came in at JPY -399M, a JPY 40M improvement versus the revised forecast of JPY -439M. Adjusted net income was JPY 310M versus the revised forecast of JPY 334M (achievement rate 92.8%). Extraordinary gains included JPY 710M in gains on the sale of shares in affiliates, while extraordinary losses comprised JPY 304M in impairment losses, JPY 26M in business withdrawal losses, and JPY 30M in expenses related to the corporate name change. The key driver behind the wider net loss was JPY 111M in deferred income tax adjustments (reversal of deferred tax assets).

Performance By Business Segment

Strong Performers
  • Proprietary Brand (Beauty & Cosmetics): H2 revenue of JPY 1,583M driven by the consolidation of Kanarabo (Q3, Fujiko/b idol) and HaD (Q2, bialne). Fujiko's H2 revenue of JPY 538M made it the largest brand, with PMI-driven EC revenue growth of +48.6%
  • MiiS Brand: Full-year quarterly revenue tracked at JPY 162M → 186M → 207M → 179M. New product "mm flora*Bubble" capitalized on the carbonated beauty trend, surpassing 20,000 units. Proprietary EC channel maintained high ASP at JPY 7,025 across 17,623 purchasers
  • Planning & Contract Manufacturing (Matsumura Shoten): Full-year revenue of JPY 679M (+77.1% YoY), the first full-year contribution following its October 2024 group entry. Defensive PMI (operational DX, budget vs. actual management) is strengthening the operating foundation
Underperformers
  • Other New Business (Formerly Brand Partner): Revenue of JPY 1,184M (-25.0% YoY), weighed down by clients pulling back on advertising budgets and accelerating in-house marketing capabilities. The lifestyle segment was divested in Q4, narrowing focus to food & beverage
  • Kanarabo Retail Channels: Sales underperformed initial plans amid intensifying competition and changing consumer trends in the variety store and general retail market

Progress Versus Full-Year Guidance

Full-year results came in largely in line with the revised plan, with revenue at 100.7% of target. Operating loss improved to JPY -399M versus the revised forecast of JPY -439M. Adjusted net income of JPY 310M fell slightly short of the revised forecast of JPY 334M (achievement rate 92.8%), though the completion of the unprofitable business cleanup can be viewed as laying the foundation for earnings recovery from next fiscal year onward.

ItemFull-Year ActualFull-Year Forecast (Revised)Progress Rate
RevenueJPY 4,129MJPY 4,100M100.7%
Operating IncomeJPY -399MJPY -439M-
Adjusted Net IncomeJPY 310MJPY 334M92.8%
  • The Proprietary Brand segment tends to see elevated revenue in Q3 (Oct–Dec) driven by the year-end holiday season (MiiS Q3: JPY 207M; Fujiko revenue concentrated in H2 including Q3)
  • The Other New Business segment (SNS marketing support) tends to see higher order volume in Q3 as clients accelerate fiscal year-end budget deployment

Changes To Guidance

Next fiscal year's guidance calls for +59.9% revenue growth, primarily driven by the full-year consolidation of Kanarabo. Operating income is expected to turn profitable at JPY 50M, though this remains a razor-thin margin. A key focus will be the recovery to adjusted EBITDA of JPY 324M. No guidance was provided for recurring profit or net income.

  • Revenue: JPY 6,602M (+59.9%)
  • Operating Income: JPY 50M (return to profitability)
  • Adjusted EBITDA: JPY 324M (return to profitability)
  • Adjusted Net Income: JPY 128M (-58.7%)

Commentary On Shareholder Returns

Annual dividend for FY2026 is JPY 0.00 (unchanged from the prior year). Annual dividend for FY2027 (forecast) is also JPY 0.00. No mention of changes to dividend payout ratio or share buyback policies. The company continues to prioritize growth investments (M&A).

Financial Position

Total assets expanded +58.9% YoY to JPY 5,648M, driven by goodwill additions and increased borrowings associated with M&A activity. The equity ratio deteriorated from 32.7% to 19.2%, reflecting a rapid increase in financial leverage. Retained earnings fell to JPY -267M, turning negative.

  • Key Figures
  • Leverage Metrics
ItemValueAdditional Information
Cash and DepositsJPY 689M+26.8% YoY
Total AssetsJPY 5,648M+58.9% YoY
└ Total Current AssetsJPY 2,620M+41.2% YoY
└ Total Non-Current AssetsJPY 3,011M+79.2% YoY
GoodwillJPY 2,311M+203.3% YoY
Shareholders' EquityJPY 1,085M-6.7% YoY
Interest-Bearing Debt (Total)JPY 3,541M+78.3% YoY
└ Short-Term BorrowingsJPY 820M-
└ Current Portion of Long-Term DebtJPY 944M-
└ Long-Term DebtJPY 1,556M-
└ Bonds (Current + Non-Current)JPY 210M-
EBITDAJPY -186MOI -399 + D&A 50 + Goodwill Amortization 161; our estimate

News Released Alongside The Earnings Announcement

  • 2026/05/11
    Oral beauty brand "MiiS" launched the "LIFT BRUSH," a lift-up-focused electric toothbrush, via crowdfunding platform Makuake. Targets incremental revenue from high-ASP products Launch of 'MiiS LIFT BRUSH,' a Lift-Up Electric Toothbrush Targeting Facial Muscles via Oral Care — Pre-Sale Begins Today on Makuake
  • 2026/05/11
    Full-year earnings briefing for retail and institutional investors scheduled for May 14, 2026, to be held online with CEO Ryo Okubo presenting Notice Regarding FY2026 Full-Year Earnings Briefing for Retail and Institutional Investors

Major Announcements During The Quarter

  • 2026/02/18
    Resolved to divest all shares of Rice Curry LS — the entity succeeding the lifestyle-segment SNS marketing support business — to Lovable Marketing Group for JPY 700M. Concentrating management resources on the Brand Produce domain Notice Regarding Change in Subsidiary (Share Transfer)
  • 2026/03/05
    Completed payment for a third-party allotment to ULTIMATE CLASSIC INVESTMENT LLC, raising approximately JPY 295M. The entity becomes the second-largest shareholder at 11.03% of voting rights. Proceeds earmarked for Middle East market expansion and growth-return-oriented treasury investments Progress Update: Completion of Payment for Third-Party Allotment of New Shares and Change in Major Shareholders
  • 2026/03/23
    Consolidated subsidiary Tokakai (general incorporated association) made Harukikai (medical corporation operating dental clinics) a consolidated subsidiary. Expanding the clinic business through cross-selling with the MiiS brand Notice Regarding Consolidation of Medical Corporation Harukikai as a Subsidiary by a Consolidated Subsidiary
  • 2026/03/31
    Booked JPY 304M in goodwill impairment and JPY 26M in business withdrawal losses related to RiLi operations, along with JPY 646M in gains on the sale of Rice Curry LS. Revised full-year earnings guidance, signaling a cleanup of unprofitable businesses and resource reallocation to high-growth areas Notice Regarding Recording of Extraordinary Gains and Losses (Estimated) and Revision to Full-Year Consolidated Earnings Guidance
  • 2026/03/31
    Published VISION2029 (mid-term management plan). Targets revenue of JPY 15B, operating income of JPY 1.5B, and market capitalization of JPY 30B by FY2029, with M&A-driven brand portfolio expansion and overseas development positioned as key growth drivers VISION2029 — Mid-Term Management Plan — Presentation Materials

Large-Shareholding Filings / Material Proposals Over The Past Year

  • ULTIMATE CLASSIC INVESTMENT LLC: 0% → 11.03% (2026/03/05) — Pure investment. Respects current management's strategic direction and supports long-term corporate value enhancement
  • Ryo Okubo (CEO): 36.84% → 37.46% (2025/08/07) — Pure investment (including stock options; 220,000 shares pledged as collateral under a loan agreement with Tokai Tokyo Securities)
Disclaimer

Envalith, Inc. ("Envalith") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.

  • Purpose and Disclaimer Regarding Investment Decisions

    This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and Envalith and subject company shall not be involved in any such investment decisions.

  • Information Sources, Accuracy, and Disclaimer of Warranty

    This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. Envalith has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by Envalith using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, Envalith and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. Envalith and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.

  • Limitation of Liability

    Envalith and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.

  • Potential Conflicts of Interest

    Envalith may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.

  • No Obligation to Change or Update Content

    The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that Envalith is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.

  • Governing Language

    This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.

  • Copyright

    All rights (including copyrights) relating to this report belong to Envalith. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of Envalith is strictly prohibited.

  • Use for Other Investment Products

    Except where Envalith has provided prior written approval, the use of this report and the trademarks or trade names of Envalith or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.